Scolr cuts losses on reduced R&D spending, Q2 revs down
Scolr Pharma reduces losses despite drop in revenue by cutting spending on product R&D and operations.
Archives for August 15, 2010
Ranbaxy’s CEO stepping down and appointments at Avid, the USP and Novavax – People on the move
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including Ranbaxy’s CEO stepping down and appointments at Avid, the USP and Novavax.
Warnex sees Q2 growth; Indian business expansion
Warnex says demand for contract analysis services increase in Q2 thanks to expansion in diagnostics market and forecasts growth opportunities in India.
Cyprotex sees profits down in H1, but predicts US growth
Pre-clinical ADME contractor Cyprotex upbeat about 2010 despite drop in profit, citing new US opportunities post-Apredica acquisition.
BASi posts Q3 operating profit despite lower revenues
Bioanalytical Systems, Inc (BASi) posted an operating profit in the third quarter, overturning a loss 12 months ago, as lower expenses offset a slight dip in revenue.
Clodalkin plans pharma biz growth
Clondalkin aims to expand its pharmaceutical cartoning and labelling business with reorganised operations in Ireland and Poland.
EMA, FDA seek applicants for joint GMP inspections
The EMA and FDA are seeking pharma manufacturers to participate in a joint GMP (good manufacturing practice) inspection pilot programme.